Syngene27 Mar 2025 05:32
“Incorporated in 1993, Syngene is listed separately on the Indian stock exchanges – NSE and BSE. With a unique business model, a talent pool of 5656 scientists, scientific expertise across new therapeutic modalities, an experienced management team, and an independent Board committee, Syngene works for clients around the globe, delivering innovation that benefits human and animal health. As a strategic partner to its clients, often working as an extension of their internal scientific teams, Syngene offers innovative, flexible, and efficient approaches to scale up rapidly. This, in turn, enables faster go-to-market and access to patients.”
https://www.syngeneintl.com/about-us/